At a glance
ClinicalIndex Comparison RecordN/ACompleted· 39 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Defining Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
In Brief
An observational study for Alpha 1-Antitrypsin Deficiency. Completed, enrolled 39 participants across 1 site.
Detailed Summary
The investigators hypothesize that environmentally influenced histone modifications regulate AM mediated inflammation, contributing to a variable clinical course of AATD, and may also influence or be influenced by the activity of AAT augmentation therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlpha 1-Antitrypsin Deficiency
CountriesUnited States
CollaboratorsMedical University of South Carolina
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedFeb 2016
Primary CompletionNov 2018
Study CompletionJul 2020
TodayJul 2026
First PostedFeb 25, 2016
Enrollment StartDec 1, 2015
Primary CompletionNov 1, 2018
Study CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.4 years ago